JN122
JN122, a spiroindoline-containing molecule, is a MDM2 inhibitor. JN122 Inhibits MDM2/p53 protein–protein interaction and exerts robust in vivo antitumor efficacy. JN122 has antiproliferative activity in HCT-116 cells and HEK-293 cells with IC50 values of 39.6 nM and 4.28μM, respectively. JN122 can promote activation of p53 and its target genes, inhibited cell cycle progression, and induced cell apoptosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3035577-19-3
- Formule: C33H37Cl2N3O4
- Masse moléculaire:610.57
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
IC50: 39.6 nM (HCT-116 cells); 4.28μM (HEK-293 cells)[1].
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
2.9 nM
Compound: (-)60; JN122
|
Growth inhibition of human A549 cells harboring p53 incubated for 4 days by CCK-8 assay
Growth inhibition of human A549 cells harboring p53 incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
| HCT-116 | IC50 |
<1 nM
Compound: (-)60; JN122
|
Antiproliferative activity against human HCT-116 cells harboring p53 assessed inhibition of cell growth incubated for 4 days by celltiter-glo assay
Antiproliferative activity against human HCT-116 cells harboring p53 assessed inhibition of cell growth incubated for 4 days by celltiter-glo assay
|
[PMID: 38062557] |
| HCT-116 | IC50 |
13.6 nM
Compound: XVI; JN122
|
Antiproliferative activity against human HCT-116 cells incubated for 4 days by CCK8 assay
Antiproliferative activity against human HCT-116 cells incubated for 4 days by CCK8 assay
|
[PMID: 38581730] |
| HeLa | IC50 |
12.24 nM
Compound: (-)60; JN122
|
Growth inhibition of human HeLa cells harboring p53 incubated for 4 days by CCK-8 assay
Growth inhibition of human HeLa cells harboring p53 incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
| HepG2 | IC50 |
0.32 nM
Compound: (-)60; JN122
|
Growth inhibition of human HepG2 cells harboring p53 incubated for 4 days by celltiter glo assay
Growth inhibition of human HepG2 cells harboring p53 incubated for 4 days by celltiter glo assay
|
[PMID: 38062557] |
| MOLM-13 | IC50 |
49.9 nM
Compound: (-)60; JN122
|
Growth inhibition of human MOLM-13 cells incubated for 2 days by CCK-8 assay
Growth inhibition of human MOLM-13 cells incubated for 2 days by CCK-8 assay
|
[PMID: 38062557] |
| MOLM-13 | IC50 |
0.2 nM
Compound: XVI; JN122
|
Antiproliferative activity against human MOLM-13 cells incubated for 2 days by CCK8 assay
Antiproliferative activity against human MOLM-13 cells incubated for 2 days by CCK8 assay
|
[PMID: 38581730] |
| MSTO-211H | IC50 |
9.48 nM
Compound: (-)60; JN122
|
Growth inhibition of human MSTO-211H cells harboring p53 incubated for 4 days by CCK-8 assay
Growth inhibition of human MSTO-211H cells harboring p53 incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
| NCI-H460 | IC50 |
0.26 nM
Compound: (-)60; JN122
|
Growth inhibition of human NCI-H460 cells harboring p53 incubated for 4 days by CCK-8 assay
Growth inhibition of human NCI-H460 cells harboring p53 incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
| SW480 | IC50 |
7.1 nM
Compound: (-)60; JN122
|
Growth inhibition of human SW480 cells incubated for 4 days by CCK-8 assay
Growth inhibition of human SW480 cells incubated for 4 days by CCK-8 assay
|
[PMID: 38062557] |
Chemical Information
-
CAS No. 3035577-19-3
-
Masse moléculaire 610.57
-
Formule C33H37Cl2N3O4
-
SMILES
CCN1[C@H]([C@@H]([C@@]2([C@@H]1CC(C)(C)C)CNC3=CC(Cl)=CC=C32)C4=CC(Cl)=CC=C4)C(NC5=CC=C(C=C5OC)C(O)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)